Vaccine bt16

Kikelo47 Kikelo47 795 views May 12, 2024
Yellow BT-10: Booster Xros Encounter Moderate
Playtest Purchase

Ban List Violation

This deck does not conform to the current ban list:

  • T.K. Takaishi (BT14-084) is restricted to 1 copy, but this deck contains 4.
Deck Primer

Yellow vaccine without get into full lifetime debt

Deck List

Digimon (33)
3 Kudamon BT13-034
$0.51 Lv.3 1000
4 Patamon BT14-033
$12.24 Lv.3 1000
2 Pillomon BT9-033
$0.13 Lv.3 2000
2 Ukkomon BT16-082
$6.44 Lv.3 2000
2 Angemon BT14-102
$3.74 Lv.4 6000
4 Rapidmon BT8-039
$1.10 Lv.4 6000
4 Rapidmon ST17-06
$0.40 Lv.4 7000
1 Angewomon BT15-038
$3.49 Lv.5 7000
3 MagnaAngemon BT14-037
$0.83 Lv.5 8000
1 Magnamon (X Antibody) BT16-102
$25.72 Lv.6 12000
2 MegaGargomon ST17-08
$0.27 Lv.6 12000
1 Rapidmon (X Antibody) BT16-101
$13.56 Lv.6 11000
2 Venusmon BT10-042
$5.49 Lv.6 12000
1 Omnimon: Merciful Mode BT9-083
$1.04 Lv.7 15000
1 ShineGreymon: Ruin Mode EX4-074
$12.81 Lv.7 15000
Option (10)
4 Emissary of Hope BT14-093
$0.18
2 Heaven's Judgement EX4-068
$0.35
3 Physical Training P-105
$0.57
1 Reinforcing Memory Boost! BT6-100
$0.23
Tamer (7)
1 Kari Kamiya BT15-084
$0.30
4 T.K. Takaishi BT14-084
$0.22
2 T.K. Takaishi BT1-087
$1.72
Egg Deck (5)
1 Kyaromon BT13-003
$0.26 Lv.2
4 Tokomon BT14-003
$0.33 Lv.2

Card Types

Digimon 33
Option 10
Tamer 7
Digi-Egg 5

Levels

Lv.3 11
Lv.4 10
Lv.6 6
Lv.2 5
Lv.5 4
Lv.7 2

Colors

Yellow 45
Green 6
White 3
Purple 1

Play Cost

1 Cost 4
2 Cost 3
3 Cost 15
4 Cost 7
6 Cost 7
7 Cost 8
11 Cost 1
12 Cost 1
13 Cost 2
14 Cost 1
15 Cost 1

Traits

Holy Warrior 11
Mammal 6
Archangel 4
Holy Beast 3
Ancient Fairy 2
Angel 2
Machine 2
X Antibody 2

Blocks

Block 00 2
Block 01 10
Block 02 13
Block 03 33
Block 04 3

Other Yellow Decks

Yellow

dynasmon

PETERLUIS889
PETERLUIS889 (5 hours ago)
21 0
Yellow

Jupivid

Nerogane
Nerogane (8 hours ago)
13 0
Yellow

Armor-dillo Angels

An Armor Control deck centered around Ar...

MajesticElectric
MajesticElectric (12 hours ago)
22 0

Comments

No comments yet…

You must be logged in to comment.